Skip to content

AOD-9604

Based on the available research, AOD-9604 has received limited clinical investigation, with most published studies focusing on analytical detection methods rather than therapeutic efficacy.

Animal Research

The most substantial therapeutic research identified was a single animal study examining AOD-9604's potential for treating osteoarthritis. This study, published in Annals of Clinical and Laboratory Science in 2015, investigated intra-articular injections of AOD-9604 (with or without hyaluronic acid) in a rabbit osteoarthritis model. However, the specific study design, sample size, and outcomes are not detailed in the available evidence.

Detection and Analytical Studies

The majority of published research on AOD-9604 centers on analytical chemistry and sports doping detection methods. Multiple studies have developed and refined mass spectrometry techniques for identifying AOD-9604 in biological samples:

  • A 2015 study in Drug Testing and Analysis examined the detection and in vitro metabolism of AOD-9604
  • A 2014 case report described the identification and characterization of AOD-9604 in pharmaceutical preparations seized by Belgian authorities
  • Additional research has focused on broader peptide detection methods that include AOD-9604

Clinical Evidence Gap

Notably absent from the literature are randomized controlled trials or other rigorous clinical studies evaluating AOD-9604's safety and efficacy in humans. While review papers from 2026 discuss peptide therapies in sports medicine and orthopedics more broadly, no specific clinical trial data for AOD-9604 was identified in the search results.

The research evidence for AOD-9604 remains extremely limited, consisting primarily of analytical detection methods and a single animal study. No human clinical trials were found, representing a significant gap in understanding this compound's therapeutic potential and safety profile.

This information is for educational purposes only and should not be considered medical advice. Consult healthcare professionals for treatment decisions.

Free account required

Research papers requires a free AXIFI account to access clinical data, safety profiles, and research papers.